Vaccine platform technologies

Rapid vaccine development

Using platform technologies for the rapid development of vaccines.

AVRA will embrace recent advances in gene and protein-based approaches for vaccination. Such advances include DNA and RNA vaccines, virus-like particles, recombinant subunit proteins, bacterial reverse vaccinology and surface-omics that are utilised and optimised for vaccine development.